Inhibiting TRAF2-mediated Activation of NF-kappaB Facilitates Induction of AP-1

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2010 Feb 6

PMID 20133937

Citations 15

Authors

Sunil K Manna

Banaganapalli Babajan

Pongali B Raghavendra

Nune Raviprakash

Chitta Sureshkumar

Affiliations

Soon will be listed here.

Abstract

The compound 5-(4-methoxyarylimino)-2-N-(3,4-dichlorophenyl)-3-oxo-1,2,4-thiadiazolidine (P(3)-25) is known to possess anti-bacterial, anti-fungal, and anti-tubercular activities. In this report, we provide evidence that P(3)-25 inhibits NF-kappaB, known to induce inflammatory and tumorigenic responses. It activates AP-1, another transcription factor. It inhibits TRAF2-mediated NF-kappaB activation but not TRAF6-mediated NF-kappaB DNA binding by preventing its association with TANK (TRAF for NF-kappaB). It facilitates binding of MEKK1 with TRAF2 and thereby activates JNK and AP-1. We provide evidence, for the first time, that suggests that the interaction of P(3)-25 with TRAF2 leads to inhibition of the NF-kappaB pathway and activation of AP-1 pathway. These results suggest novel approaches to design of P(3)-25 as an anti-cancer/inflammatory drug for therapy through regulation of the TRAF2 pathway.

Citing Articles

Oral administration of bovine lactoferrin suppresses the progression of rheumatoid arthritis in an SKG mouse model.

Yanagisawa S, Nagasaki K, Chea C, Ando T, Ayuningtyas N, Inubushi T PLoS One. 2022; 17(2):e0263254.

PMID: 35148358 PMC: 8836292. DOI: 10.1371/journal.pone.0263254.

Scutellarein protects against cardiac hypertrophy via suppressing TRAF2/NF-κB signaling pathway.

Shi X, Hu Y, Jiang Y, Wu J, Zhang C, Zhang J Mol Biol Rep. 2022; 49(3):2085-2095.

PMID: 34988890 DOI: 10.1007/s11033-021-07026-0.

Relevance of Non-Targeted Effects for Radiotherapy and Diagnostic Radiology; A Historical and Conceptual Analysis of Key Players.

Mothersill C, Rusin A, Seymour C Cancers (Basel). 2019; 11(9).

PMID: 31450803 PMC: 6770832. DOI: 10.3390/cancers11091236.

An Abnormal Nitric Oxide Metabolism Contributes to Brain Oxidative Stress in the Mouse Model for the Fragile X Syndrome, a Possible Role in Intellectual Disability.

Lima-Cabello E, Garcia-Guirado F, Calvo-Medina R, El Bekay R, Perez-Costillas L, Quintero-Navarro C Oxid Med Cell Longev. 2016; 2016:8548910.

PMID: 26788253 PMC: 4691629. DOI: 10.1155/2016/8548910.

Low dose triterpene-quinone fraction from Ardisia crispa root precludes chemical-induced mouse skin tumor promotion.

Yeong L, Hamid R, Saiful Yazan L, Khazaai H, Mohtarrudin N BMC Complement Altern Med. 2015; 15(1):431.

PMID: 26638207 PMC: 4670530. DOI: 10.1186/s12906-015-0954-3.

References

Chadee D, Yuasa T, Kyriakis J . Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2. Mol Cell Biol. 2002; 22(3):737-49. PMC: 133545. DOI: 10.1128/MCB.22.3.737-749.2002. View

Manna S, Manna P, Sarkar A . Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells. Cell Death Differ. 2006; 14(1):158-70. DOI: 10.1038/sj.cdd.4401929. View

Binkowski T, Naghibzadeh S, Liang J . CASTp: Computed Atlas of Surface Topography of proteins. Nucleic Acids Res. 2003; 31(13):3352-5. PMC: 168919. DOI: 10.1093/nar/gkg512. View

Wang C, Cusack Jr J, Liu R, Baldwin Jr A . Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 1999; 5(4):412-7. DOI: 10.1038/7410. View

Manna S, Ramesh G . Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway. J Biol Chem. 2004; 280(8):7010-21. PMC: 2740382. DOI: 10.1074/jbc.M410994200. View

Shaulian E, Karin M . AP-1 in cell proliferation and survival. Oncogene. 2001; 20(19):2390-400. DOI: 10.1038/sj.onc.1204383. View

Manna S, Gangadharan C . Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells. Mol Immunol. 2009; 46(7):1340-50. DOI: 10.1016/j.molimm.2008.11.014. View

Pedretti A, Villa L, Vistoli G . VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph Model. 2002; 21(1):47-9. DOI: 10.1016/s1093-3263(02)00123-7. View

Fujioka S, Niu J, Schmidt C, Sclabas G, Peng B, Uwagawa T . NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol. 2004; 24(17):7806-19. PMC: 507000. DOI: 10.1128/MCB.24.17.7806-7819.2004. View

10.

Barkett M, Gilmore T . Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 1999; 18(49):6910-24. DOI: 10.1038/sj.onc.1203238. View

11.

Manna S, Zhang H, Yan T, Oberley L, Aggarwal B . Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem. 1998; 273(21):13245-54. DOI: 10.1074/jbc.273.21.13245. View

12.

Baeuerle P, Baichwal V . NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol. 1997; 65:111-37. View

13.

Kriehuber E, Bauer W, Charbonnier A, Winter D, Amatschek S, Tamandl D . Balance between NF-kappaB and JNK/AP-1 activity controls dendritic cell life and death. Blood. 2005; 106(1):175-83. DOI: 10.1182/blood-2004-08-3072. View

14.

Hsu H, Shu H, Pan M, Goeddel D . TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996; 84(2):299-308. DOI: 10.1016/s0092-8674(00)80984-8. View

15.

Rayet B, Gelinas C . Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999; 18(49):6938-47. DOI: 10.1038/sj.onc.1203221. View

16.

Kim J, Joe C, Choi E . Role of receptor-interacting protein in tumor necrosis factor-alpha -dependent MEKK1 activation. J Biol Chem. 2001; 276(29):27064-70. DOI: 10.1074/jbc.M009364200. View

17.

Sarkar A, Sreenivasan Y, Ramesh G, Manna S . beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis. J Biol Chem. 2004; 279(32):33768-81. DOI: 10.1074/jbc.M403424200. View

18.

Manna S, Aggarwal B . Lipopolysaccharide inhibits TNF-induced apoptosis: role of nuclear factor-kappaB activation and reactive oxygen intermediates. J Immunol. 1999; 162(3):1510-8. View

19.

Wisdom R, Johnson R, Moore C . c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 1999; 18(1):188-97. PMC: 1171114. DOI: 10.1093/emboj/18.1.188. View

20.

Park Y, Ye H, Hsia C, Segal D, Rich R, Liou H . A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell. 2000; 101(7):777-87. DOI: 10.1016/s0092-8674(00)80889-2. View